Azelis: Transparency Notification From EQT VIII Fund

02 Mar 2026 18:10 CET

Regulatory News:

In accordance with Article 14 of the Belgian Transparency law of May 2, 2007, Azelis Group NV (Brussels:AZE) announces that today, it has received a transparency notification from EQT VIII Fund.

1. Summary of the notification

EQT VIII Fund reported in its notification dated 27 February 2026, that on 26 February 2026, following a disposal of voting securities, its participation decreased and crossed downwards the lowest threshold of 3.00% in Azelis Group NV.

On 26 February 2026, EQT VIII Fund (taking into account the holding of its affiliates) no longer owned any Azelis shares with voting rights, representing 0.00% of the total number of shares issued by the company (243,921,719), versus 24,226,853 shares representing 9.93% in its previous notification dated 14 November 2025.

2. Content of the notification

Reason for the notification

Acquisition or disposal of voting securities or voting rights
Downward crossing of the lowest threshold

Notification by

A parent undertaking or a controlling person

Persons subject to the notification requirement

Date on which the threshold is crossed

26 February 2026

Threshold that is crossed (in %)

3%

Denominator

243,921,719

Notified Details

Chain of controlled undertakings through which the holding is effectively held, if applicable

Akita I S. à r. l. (in voluntary liquidation) is controlled by EQT VIII Investments S. à r. l. that is controlled by EQT VIII SCSp. EQT VIII SCSp is controlled by EQT VIII Collect SCSp. EQT VIII Collect SCSp is not controlled by any of its shareholders. EQT VIII Collect SCSp is managed by EQT Fund Management S.à r.l.

3. Further information

The full transparency notification as well as this press release can be consulted on the Azelis Group NV’s website.

··················· END ···················

About Azelis

Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry, present in 64 countries across the globe with over 4,100 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a comprehensive portfolio of complementary products to more than 65,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.1 billion (2025). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application laboratories, our award-winning teams develop innovative and sustainable formulations and provide technical guidance throughout the product development process. We combine global market reach with a local footprint to offer reliable, integrated, and unique digital services to local customers and attractive business opportunities to principals. Recognised for our sustainability leadership, we are committed to responsible growth that positively impacts people, communities and the planet. Through the application of science and deep market expertise, we act as catalysts for innovation, enabling our customers to win and our principals to grow.

Innovation through formulation

www.azelis.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260302523131/en/

Azelis
investor-relations@azelis.com